* Biote Corp BTMD.OQ reported a quarterly adjusted loss
of 15
cents per share for the quarter ended in June, higher than the
same quarter last year, when the company reported EPS of -25
cents. The mean expectation of four analysts for the quarter
was for earnings of 9 cents per share. Wall Street expected
results to range from 4 cents to 14 cents per share.
* Revenue fell 0.2% to $49.17 million from a year ago;
analysts
expected $49.06 million.
* Biote Corp's reported EPS for the quarter was a loss of 19
cents.
* The company reported a quarterly loss of $6.32 million.
* Biote Corp shares had fallen by 6.7% this quarter and
gained 41.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 18.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the professional
information services peer group is also "buy"
Wall Street's median 12-month price target for Biote Corp is
$9.00
This summary was machine generated from LSEG data August 8 at
10:37 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jan. 1 0001 0.09 -0.15 Missed
Mar. 31 2024 0.03 -0.06 Missed
Dec. 31 2023 0.08 0.18 Beat
Sep. 30 2023 0.08 0.24 Beat